Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss

April 21, 2005

By Jennifer Boggs

Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo

April 20, 2005

By Jennifer Boggs

Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo

April 20, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...